Harlingen Medical Center Hosts 6th Annual Charity Golf Tournament

Translate to Spanish or other 102 languages!

 Mega Doctor News

- Advertisement -

HARLINGEN – Harlingen Medical Center is set to host one of the most exciting charity events of the year, The Harlingen Medical Center 6th Annual Charity Golf Tournament!  The philanthropy-centered outing will take place on Saturday, November 12, 2016, at the luxurious Rancho Viejo Resort and Country Club!  Check-in is set to begin at 7:00 a.m., at the country club’s Registration Hall (located at the resorts main entrance off of Highway 77), followed by Tee Off at 8:00 a.m.

The Harlingen Medical Center 6th Annual Charity Golf Tournament will raise funds to benefit a local charitable organization in South Texas – while giving participants an opportunity to enjoy 18-holes of golf on the beautiful greens at Rancho Viejo.  The golf course features natural terrain, barrancas, resacas, and narrow fairways with strategically designed landing areas that will be pleasing to all who play.

The charity event will also feature a hole in one GRAND PRIZE, and, a closest to the hole prize winner!  There will be plenty of raffle gift items and door prizes!  The top-three performing teams will also receive trophies and cash prizes! 

- Advertisement -

All Team Registrants will enjoy complimentary breakfast, lunch, and ice cold beverages! 

For more information regarding the charity event, team registration, and corporate sponsorships, please review the attached material.  You may also contact Manny Chacon, Business Development at Harlingen Medical Center, at Mchacon@PrimeHealthCare.com.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Embolism Treatment Developed at University of Michigan receives FDA clearance 

Patients with persistent blood clots require frequent medical interventions just to survive. Yet despite this critical need, there have been few advancements in how these patients are treated. 

FDA Approves Once-Weekly Generic Hormone Therapy Patch for Women

The U.S. Food and Drug Administration approved the first generic of Climara Pro (estradiol and levonorgestrel transdermal system, 0.045 mg per day/0.015 mg), a transdermal hormone therapy patch for women with an intact uterus applied once a week. The approval aligns with FDA’s Public Health Pillar: Increasing Access to Affordable Medicines & Medical Products.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.

Texas Oncology Expands Cancer Care With New McAllen West Clinic

Texas Oncology celebrated the grand opening of its McAllen West clinic Sept. 29, expanding cancer treatment, diagnostic, and research capabilities in the Rio Grande Valley as the organization continues its presence in the region, spanning more than 40 years.
- Advertisement -